Lv1
46 积分 2025-01-30 加入
Efruxifermin: one step closer to disease-modifying therapy in fibrotic MASH
2天前
已完结
Safety and efficacy of once-weekly efruxifermin versus placebo in metabolic dysfunction-associated steatohepatitis (HARMONY): 96-week results from a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
2天前
已完结
Fibroblast bioelectric signaling drives hair growth
3天前
已完结
A mechano-resistance mechanism in skin adapts to terrestrial locomotion
15天前
已完结
A mechano-resistance mechanism in skin adapts to terrestrial locomotion
15天前
已关闭
Cancer immunology data engine reveals secreted AOAH as a potential immunotherapy
21天前
已完结
Optimization of a novel 2+2 BCMA x CD3 bispecific antibody for minimized cytokine release and potent efficacy
22天前
已完结
Efficacy and safety of intravenous induction and subcutaneous maintenance therapy with guselkumab for patients with Crohn's disease (GALAXI-2 and GALAXI-3): 48-week results from two phase 3, randomised, placebo and active comparator-controlled, double-blind, triple-dummy trials
23天前
已完结
Design of high specificity binders for peptide-MHC-I complexes
25天前
已完结
Comprehensive human proteome profiles across a 50-year lifespan reveal aging trajectories and signatures
25天前
已完结
皖公网安备34019202002308
